Hiv Clinical Trial
— IDEaLOfficial title:
Identifying Efficient Linkage Strategies for Men
Verified date | July 2023 |
Source | University of California, Los Angeles |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
HIV self-testing (HIVST) has been found to be a highly acceptable approach for men to learn of their HIV status and has resulted in increased testing uptake. However, rates of antiretroviral therapy (ART) initiation among those tested with HIVST are difficult to capture. This clinical trial will test varying approaches to ART initiation and retention among men who test positive using HIVST to learn about the most effective strategy to engage men in ART services.
Status | Active, not recruiting |
Enrollment | 569 |
Est. completion date | June 15, 2025 |
Est. primary completion date | March 15, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 15 Years and older |
Eligibility | Men: Inclusion Criteria: - =15 years of age - Tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold) - Not currently engaged in ART services, defined as: - Tested HIV-positive =14 days and not on ART =14 days after testing HIV-positive; - =14 days late for the first four-week follow up appointment; or - Initiated ART but =60 days late for last ART appointment; - Has not taken ART in the past 7-days, as indicated by a point of care (POC) urine assay - Living inside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes) Exclusion Criteria: - <15 years of age - Never tested HIV positive using Ministry of Health standard algorithm (Determine + Unigold) - Tested HIV-positive <14 days ago - Currently engaged in ART services, defined as: - Initiated ART - <14 days late for the first four-week follow up appointment - Initiated ART and <60 days late for last ART appointment - Has taken ART in the past 7-days, as indicated by a point of care (POC) urine assay - Living outside the facility catchment area (defined as any area that HCWs from the study facility routinely visit for tracing purposes) Female partner Inclusion Criteria: - =15 years of age - Male partner enrolled in the study - Male partner agrees that the female can be recruited for an in-depth interview Exclusion Criteria: - <15 years of age - Male partner is not enrolled in the study - Male partner does not agree that the female can be recruited for an in-depth interview |
Country | Name | City | State |
---|---|---|---|
Malawi | Partners in Hope | Lilongwe |
Lead Sponsor | Collaborator |
---|---|
University of California, Los Angeles | Bill and Melinda Gates Foundation, Boston University, Charles University, Czech Republic, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Partners in Hope, Malawi |
Malawi,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of men who are retained on ART early | Proportion of men who initiate ART at 3-months and attended their 4-week ART refill appointment at 4-month after enrollment. Sourced from medical chart reviews. | 4-months. | |
Secondary | Proportion of men who initiate ART | Proportion of men who initiate at 3-months after enrollment. Sourced from medical chart reviews. | 3-months | |
Secondary | Any adverse events self-reported by female ART client or male partner | Self-report of any adverse event from female ART client (IPV, unwanted disclosure, end of relationship) and their male partners (unwanted disclosure) who were identified as HIV-positive. Sourced from follow-up surveys. | 4-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |